NCT06711744 is a NA clinical trial of Implant stability quotient in Bone Healing, sponsored by University of Rome Tor Vergata.

Who is sponsoring NCT06711744?

NCT06711744 is sponsored by University of Rome Tor Vergata.

What drugs are being tested in NCT06711744?

Interventions in NCT06711744: Implant stability quotient.

What condition does NCT06711744 study?

NCT06711744 studies Bone Healing, Implant Stability.

Is NCT06711744 still recruiting?

NCT06711744 is currently recruiting now. Last updated 28 March 2025.

Last reviewed 2025-03-28 · How we verify

NCT06711744

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

ISQ Differences Between Different Implants in Post-extraction Sockets

Recruiting now NA Last updated 28 March 2025

What this trial tests

NA trial testing Implant stability quotient in Bone Healing in 30 participants. Currently enrolling.

Timeline

31 January 2025

Primary endpoint
31 December 2026

28 February 2027

Quick facts

Lead sponsor	University of Rome Tor Vergata
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	diagnostic
Enrollment	30
Start date	31 January 2025
Primary completion	31 December 2026
Estimated completion	28 February 2027
Sites	1 location across Italy

Drugs / interventions tested

Implant stability quotient

Conditions studied

Bone Healing — all drugs for Bone Healing →
Implant Stability — all drugs for Implant Stability →

Sponsor

University of Rome Tor Vergata

Who can join

Adults 18 to 99, any sex, with Bone Healing or Implant Stability. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Two different implants will be used in post-extraction sockets and ISQ will be recorded monthly from insertion moment to 12 months of follow up to understand if ISQ can be affected by implant macro design

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Bone Healing

Currently open trials in the same condition.

NCT06624982 — Determinants of Bone Dimensional Changes After Extraction and Alveolar Ridge Preservation · recruiting
NCT07190950 — Effects of Low-level Laser Therapy on Soft and Hard Tissue Healing After Impacted Mandibular Third Molar Extraction · NA · recruiting

Other University of Rome Tor Vergata trials

Trials by the same sponsor.

NCT07510698 — Same-Day Awake Mastectomy With Immediate Breast Reconstruction for Patients With Breast Cancer · NA · recruiting
NCT07313358 — 10119473 -VIROMARKERS HDV Biomarkers Study · not yet recruiting
NCT07286461 — VIROMARKERS GA n.101194735 - CMV and TTV Biomarkers Study Protocol · not yet recruiting
NCT07067749 — Treatment Expedition With MRI Processing and Optimization for Muscle Invasive Bladder Cancer · Phase 3 · recruiting
NCT06745232 — New Stereophotogrammetry System to Capture Complete-arch Impression · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06711744 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Rome Tor Vergata
Last refreshed: 28 March 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06711744.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing